← Browse by Condition
Medical Condition
urogenital neoplasms
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1, Phase 2
NCT04923178
Recruiting
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Enrollment
1,100 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04519151 Phase 2
Recruiting
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Enrollment
24 pts
Location
Israel
Sponsor
Sheba Medical Center
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Enrollment
365 pts
Location
United States, Canad...
Sponsor
Marengo Therapeutics, Inc.